S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
NASDAQ:QNRX

Quoin Pharmaceuticals - QNRX Earnings Date, Estimates & Call Transcripts

$4.78
-0.04 (-0.83%)
(As of 08/12/2022 09:15 PM ET)
Add
Compare
Today's Range
$4.70
$5.09
50-Day Range
$3.85
$19.80
52-Week Range
$3.58
$444.00
Volume
809,900 shs
Average Volume
659,389 shs
Market Capitalization
$3.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data

QNRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

QNRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quoin Pharmaceuticals Analyst Forecasts

Current Year EPS Consensus Estimate: $-6.5 EPS
Next Year EPS Consensus Estimate: $-5.25 EPS

QNRX Earnings Date and Information

Quoin Pharmaceuticals last announced its quarterly earnings results on May 23rd, 2022. The reported ($2.50) EPS for the quarter. Quoin Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for Quoin Pharmaceuticals are expected to grow in the coming year, from ($6.50) to ($5.25) per share. Quoin Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, August 18th, 2022.

Quoin Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/18/2022
(Confirmed)
        
5/23/2022Q1 2022($2.50)($2.50)($0.20)
8/24/2021Q2 2021($21.50)($21.50)($1.72)
3/29/2021Q4 2020($19.50)($19.50)($1.56)
11/20/2020Q3 2020($6.00)($6.00)($0.48)
8/12/2020Q2 2020($34.50)($34.50)($2.76)
5/21/2020Q1 2020($11.00)($11.00)($0.88)
4/3/2020Q4 2019($38.50)($38.50)($3.08)
11/19/2019Q3 2019($30.50)($30.50)($2.44)
8/13/2019Q2 2019($5.00)($5.00)($0.40)
5/21/2019Q1 2019($40.00)($40.00)($3.20)
3/18/2019Q4 2018($40.00)($40.00)($3.20)
11/13/2018Q3 2018($70.00)($72.50)($2.50)($5.80)
8/9/2018Q2 2018($72.50)($65.00)+$7.50($5.20)
5/17/2018Q1 2018($75.00)($40.00)+$35.00($3.20)
3/19/2018Q4 2017($77.50)($40.00)+$37.50($3.20)
11/22/2017Q3 2017($75.00)($97.50)($22.50)($7.80)
8/21/2017Q2 2017($55.00)($57.50)($2.50)($4.60)
5/29/2017Q1 2017($55.00)($10.00)+$45.00($0.80)
3/23/2017Q4 2016($50.00)($2.50)+$47.50($0.20)
11/28/2016Q3 2016($52.50)($75.00)($22.50)($6.00)
9/1/2016Q2 2016($2.50)($2.50)($0.20)
7/1/2016Q1 2016($2.50)($2.50)($0.20)












Quoin Pharmaceuticals Earnings - Frequently Asked Questions

When is Quoin Pharmaceuticals's earnings date?

Quoin Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, August 18th, 2022. Learn more on QNRX's earnings history.

How much profit does Quoin Pharmaceuticals generate each year?

Quoin Pharmaceuticals (NASDAQ:QNRX) has a recorded net income of -$21.46 million. QNRX has generated $0.00 earnings per share over the last four quarters.

What is Quoin Pharmaceuticals's EPS forecast for next year?

Quoin Pharmaceuticals's earnings are expected to grow from ($6.50) per share to ($5.25) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:QNRX) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.